Physician profile
Sameh S Wahba
NPI 1154544567
$9,676.05
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,586 · 2020: $90.21.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $4,249.74 | 2019 | |
| Allergan, INC. | $2,522.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $688.80 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $375.52 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $317.30 | 2019 | |
| Lundbeck LLC | $282.25 | 2019-2020 | |
| Indivior INC. | $277.08 | 2019 | |
| Alkermes, INC. | $270.27 | 2019 | |
| Sunovion Pharmaceuticals INC. | $186.80 | 2019 | |
| Shire North American Group INC | $185.32 | 2019 | |
| Neuronetics, INC. | $68.24 | 2019 | |
| Ironshore Pharmaceuticals INC. | $67.84 | 2019 | |
| Vanda Pharmaceuticals INC. | $62.57 | 2019 | |
| Jazz Pharmaceuticals INC. | $41.08 | 2019-2020 | |
| Bausch Health US, LLC | $37.29 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $23.08 | 2019 | |
| Vertical Pharmaceuticals, LLC | $20.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Wahba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.